These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31183212)

  • 1. Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.
    Cho J; Chen JCY; Paludo J; Conboy EE; Lanpher BC; Alberts SR; Halfdanarson TR
    J Gastrointest Oncol; 2019 Jun; 10(3):582-588. PubMed ID: 31183212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
    Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
    Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
    Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
    Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
    Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
    Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
    Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
    Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Surjan RCT; de Lima TM; de Souza HP; Machado MCC; Ardengh JC
    Cureus; 2023 Jan; 15(1):e33750. PubMed ID: 36788919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
    Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
    Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
    Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
    Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma.
    Alsina AE; Franco E; Nakshabandi A; Albers C; Kemmer N; Berry AC; Finan J
    ACG Case Rep J; 2016 Aug; 3(4):e106. PubMed ID: 27807568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.
    Upadhyay R; Bleck TP; Busl KM
    Case Rep Med; 2016; 2016():8512721. PubMed ID: 27738433
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy.
    Suarez O; Perez M; Garzon M; Daza R; Hernandez G; Salinas C; Ceballos J; de Leon EP; Mugnier J; Beltrán O; Varón A
    Case Reports Hepatol; 2018; 2018():7521986. PubMed ID: 30631612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
    Chan JS; Harding CO; Blanke CD
    South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet.
    Ben-Ari Z; Dalal A; Morry A; Pitlik S; Zinger P; Cohen J; Fattal I; Galili-Mosberg R; Tessler D; Baruch RG; Nuoffer JM; Largiader CR; Mandel H
    J Hepatol; 2010 Feb; 52(2):292-5. PubMed ID: 20031247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
    Felig DM; Brusilow SW; Boyer JL
    Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration.
    Gascon-Bayarri J; Campdelacreu J; Estela J; Reñé R
    Case Rep Neurol Med; 2015; 2015():453752. PubMed ID: 25949836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.
    Eggert T; McGlynn KA; Duffy A; Manns MP; Greten TF; Altekruse SF
    United European Gastroenterol J; 2013 Oct; 1(5):351-7. PubMed ID: 24917983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
    Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
    Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrolamellar hepatocellular carcinoma mimicking ornithine transcarbamylase deficiency.
    Sulaiman RA; Geberhiwot T
    JIMD Rep; 2014; 16():47-50. PubMed ID: 24997132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy.
    Hasegawa T; Tzakis AG; Todo S; Reyes J; Nour B; Finegold DN; Starzl TE
    J Pediatr Surg; 1995 Jun; 30(6):863-5. PubMed ID: 7666324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
    Lee NR; Yhim HY; Yim CY; Kwak JY; Song EK
    Ann Pharmacother; 2011 Oct; 45(10):e56. PubMed ID: 21954449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.